Products for Research Use Only
RegisterLogin

Pivekimab

CAT: 0804-HY-P99234-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99234-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Pivekimab is a human IgG1 monoclonal antibody that targets interleukin-3 (IL-3) and CD123. Pivekimab is used to synthesize pivekimab sunirine, a CD123-directed antibody-active molecule conjugate (ADC) . Pivekimab is used in the study of blastic plasmacytoid dendritic cell neoplasm (BPDCN) [1][2].
CAS Number
2234335-84-1
UNSPSC
12352203
Target
ADC Antibody; Interleukin Related
Type
Inhibitory Antibodies
Related Pathways
Antibody-drug Conjugate/ADC Related; Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/pivekimab.html
Purity
97.19
Solubility
10 mM in DMSO
Smiles
[Pivekimab]
Molecular Weight
(145.98 kDa)
References & Citations
[1]Patrick ZM, et, al. Methods of treatment using anti-CD123 immunoconjugates. WO2020092533.|[2]Poussard, et al. Spatial Response to Pivekimab Sunirine (IMGN632) In Vivo in a BPDCN Model. Blood 142 (2023) : 2791.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 1

Alternative Products

CatalogName
MBS5818697Pivekimab
T9901A-047-01Pivekimab sunirine
GTR18338014-01Pivekimab Antibody
HB714026-01Research Grade Pivekimab
E55B0834Pivekimab (Reference antibody)
GTR18412424-01Pivekimab sunirine Antibody
A138147Pivekimab Biosimilar (Monoclonal, IgG1)
ABS-259-1mgPivekimab Biosimilar, Research Grade
ICH5775-50mgPivekimab Biosimilar - Research Grade

Popular Products